(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
NASA is shooting for the moon. A guide to the Artemis II mission - 27 Powerful Techniques to Boost Efficiency with Your Cell Phone: A Thorough Aide
- 3Courageous Climbing: Trails and Stuff for Outside Lovers
- 4Why the weirdest sea level changes on Earth are happening off the coast of Japan
- 5Building a Maintainable Closet: Individual Excursions in Moral Style
- Insurance warning signs in doctors’ offices might discourage patients from speaking openly about their health
- Jersey's wellbeing score is below UK and France
- Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump
- Bahrain cracks down on dissent as war grinds on
- L.A.'s most famous midcentury home, the Stahl House, is on the market for the 1st time, at $11K per square foot: See inside
- Figure out how to Perceive Warnings while Looking for an Auto Collision Lawyer
- Verdicts against social media companies carry consequences. But questions linger
- The Latest: Fueling begins as NASA aims to send 1st crew to the moon in 53 years
- How HIV/AIDS got its name − the words Americans used for the crisis were steeped in science, stigma and religious language
